Nam et al. (2013) 75,190 0.7% . . 0.1% . Hospitalisation 1.4% Canada Bleeding 0.2% Roth et al. (2015) 34,865 0.8% 0.09% 0.8% 0.1% 0.06% Haematoma 0.1% Australia Prostatitis 0.05% Fever 0.006% Pinksy et al. (2014) 4,836 0.8% . 0.4% . Death 0.4% USA Rectal bleeding 0.3% Roberts et al. (2002) 1,776 2.7% . 1.3% 1.9% 12.1% Rectal bleeding 1.2% USA Haematospermia 0.5% Pain 2.0% Bacteraemia 0.1% Hospitalisation 0.4% Rosario et al. (2012) 1,147 . . . . 66.0% Rectal bleeding 37.0% UK Haematospermia 93.0% Pain 44.0% Fever 20.0% Simsir et al. (2010) 2,023 . 3.0% . . . Death 0.05% Turkey Zaytoun et al. (2011) 1,438 2.2% 0.2% . 0.8% 4.4% Rectal bleeding 1.5% USA Haematospermia 0.8% Helfand et al. (2012) 85 . . . . . Erectile dysfunction 11.8% USA Kariotis et al. (2010) 434 . . . . 62% Rectal bleeding 51% Greece Haematospermia 88% Marino et al. (2015) Bacteraemia 0.4% 455 . 2.4% 1.5% . . USA Hospitalisation 5.5% Mohammed et al. (2016) 286 . 0.4% . . . Ireland Petteffi et al. (2002) Fever 15%, 1% 105 . . 30%, 7% . . Brazil Hospitalisation 3.0%
Nam et al. (2013) Canada 75,190 0.7% . . 0.1% . Hospitalisation 1.4% Bleeding 0.2% Roth et al. (2015) Australia 34,865 0.8% 0.09% 0.8% 0.1% 0.06% Haematoma 0.1% Prostatitis 0.05% Fever 0.006% Pinksy et al. (2014) USA 4,836 0.8% . 0.4% . Death 0.4% Rectal bleeding 0.3% Roberts et al. (2002) USA 1,776 2.7% . 1.3% 1.9% 12.1% Rectal bleeding 1.2% Haematospermia 0.5% Pain 2.0% Bacteraemia 0.1% Hospitalisation 0.4% Rosario et al. (2012) UK 1,147 . . . . 66.0% Rectal bleeding 37.0% Haematospermia 93.0% Pain 44.0% Fever 20.0% Simsir et al. (2010) Turkey 2,023 . 3.0% . . . Death 0.05% Zaytoun et al. (2011) USA 1,438 2.2% 0.2% . 0.8% 4.4% Rectal bleeding 1.5% Haematospermia 0.8% Helfand et al. (2012) USA 85 . . . . . Erectile dysfunction 11.8% Kariotis et al. (2010) Greece 434 . . . . 62% Rectal bleeding 51% Haematospermia 88% Marino et al. (2015) USA 455 . 2.4% 1.5% . . Bacteraemia 0.4% Hospitalisation 5.5% Mohammed et al. (2016) Ireland 286 . 0.4% . . . Petteffi et al. (2002) Brazil 105 . . 30%, 7% . . Fever 15%, 1% Hospitalisation 3.0%
1397_Final_MSAC_Assessment_Report.docx